神经调节肽 U 受体属于 G 蛋白偶联受体家族,归类为 Class A。神经调节肽 U 受体可与神经肽激素神经质素 U 和神经质素 S 结合。神经调节肽 U 受体包括 NMUR1 和 NMUR2,NMUR1 主要在胃肠道等外周组织表达,NmU-R2 主要在中枢神经系统表达。神经调节肽 U 受体能介导细胞内 Ca2+ 等信号转导,调节胃肠道、心血管、神经内分泌等多系统的生理功能,如影响平滑肌收缩、血压、摄食、能量平衡和应激反应等。神经调节肽 U 受体与癌症、疼痛、代谢性疾病、胃肠道疾病等的发生发展密切相关,是极具潜力的疾病治疗靶点[1]。
Neuromedin U Receptor belongs to the G protein-coupled receptors family and is classified as Class A. Neuromedin U Receptor can bind the neuropeptide hormones neuromedin U and neuromedin S. Neuromedin U Receptor includes NMUR1 and NMUR2. NMUR1 is mainly expressed in peripheral tissues such as the gastrointestinal tract, while NmU-R2 is mainly expressed in the central nervous system. Neuromedin U Receptor can mediate intracellular signal transduction such as Ca2+ and regulate the physiological functions of multiple systems such as the gastrointestinal tract, cardiovascular system, and neuroendocrine system, for example, affecting smooth muscle contraction, blood pressure, feeding, energy balance, and stress responses. Neuromedin U Receptor is closely related to the occurrence and development of diseases such as cancer, pain, metabolic diseases, and gastrointestinal diseases, and is a highly potential target for disease treatment[1].
CPN-219 是一种新一代六肽类 NMUR2 激动剂,可剂量依赖性地选择性激活 NMUR2,其 EC50 值为 2.2 nM。
CPN-267 (compound 7b) TFA 是一种选择性神经介质 U 受体 1 (NMUR1) 激动剂,EC50 值为 0.25 nM,可抑制小鼠体重增加,因此可用于肥胖研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号